SW
ABBV icon

SteelPeak Wealth’s AbbVie ABBV Stock Holding History

SteelPeak Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Hold
0
– -$189K – 566
2025
Q1 		– Hold
0
– – – 494
2023
Q3 		– Hold
0
– -$162K – 441
2023
Q2 		– Hold
0
– – – 402

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

SteelPeak Wealth's ABBV Position: Q2 2026 in Review

SteelPeak Wealth increased its AbbVie (ABBV) stake by 1% in Q2 2026, buying an estimated $80K and bringing the position to 37,009 shares worth $9.31M. The position accounts for 0.24% of the portfolio, ranked #86.

SteelPeak Wealth first reported a position in ABBV in Q4 2019 and has held it in 27 quarters since. The position peaked at $9.36M in Q4 2025. 2,079 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • SteelPeak Wealth held 37,009 shares of AbbVie worth $9.31M as of Q2 2026.
  • SteelPeak Wealth bought 372 AbbVie shares in Q2 2026, an estimated $80K.
  • AbbVie made up 0.24% of SteelPeak Wealth's portfolio in Q2 2026, its #86 holding.
  • SteelPeak Wealth first reported a position in AbbVie in Q4 2019 and has held it in 27 quarters since.
  • SteelPeak Wealth's AbbVie position peaked at $9.36M in Q4 2025.
  • 2,079 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on SteelPeak Wealth's 13F filing for Q2 2026, filed 13 Jul 2026.